iiinova — where your digital self keeps evolving

Reposted by Ann Mullally

Quinn Sievers @quinnsievers.bsky.social · 30/08/2026

This was a fantastic discussion!

Ann Mullally @mullallylab.bsky.social · 28/08/2026

Check out my conversation w/ @rosslevinemd.bsky.social Whether you’re a student, resident/fellow, hematologist/oncologist, cancer biologist, drug discoverer or patient, this #TheFutureofMedicine podcast is for you! @stanforddeptmed.bsky.social @mskcancercenter.bsky.social youtu.be/KNB27ZRqABI?...

youtu.be

Ross Levine on Blood Cancer, Cancer Genetics, and New Therapies

YouTube video by Stanford Department of Medicine

073

Reposted by Ann Mullally

Ya’el Courtney, PhD @scienceyael.bsky.social · 09/04/2026

Just updated my HHMI Gilliam Fellowship application guide for the 2026 cycle. Big changes this year: international PhD students and MD-PhDs can now apply, and there's a new postdoc pathway extending HHMI support up to 7 years total. www.yaelcourtney.com/resources-an...

yaelcourtney.com

HHMI Gilliam Fellowship Application Guide (From a Gilliam Fellow) | Ya'el Courtney — Ya'el Courtney

A detailed walkthrough of every component of the HHMI Gilliam Fellowship application — from the equity and inclusion statement to the community engagement plan — written by a three-year Gilliam Fellow with advice from successful applicants and HHMI leadership.

11210

Ann Mullally @mullallylab.bsky.social · 09/04/2026

After a fantastic MGR today, we are thrilled to welcome Dr. Ross Levine back for our #hematology seminar tomorrow - very thankful to Ross for such & engaging & fun visit! #MPNsm @stanforddeptmed.bsky.social @rosslevinemd.bsky.social @mskcancercenter.bsky.social

072

Reposted by Ann Mullally

Stanford Hematology Division @stanford-heme.bsky.social · 08/04/2026

✨Thrilled to welcome the esteemed Dr. Ross L. Levine for a captivating presentation at the Breakthroughs in Hematology seminar tomorrow!✨ @rosslevinemd.bsky.social @stanforddeptmed.bsky.social l @mskcancercenter.bsky.social

061

Reposted by Ann Mullally

Stanford Medicine @stanfordmedicine.bsky.social · 26/03/2026

Walk with Me: Carolyn Bertozzi, Nobel Prize–winning chemist at Stanford, uses chemical biology to understand disease and develop new treatments. Hear what sparked her love of science—and her dream superpower. stan.md/3O4mjqi @carolynbertozzi.bskyverified.social @stanfordchemistry.bsky.social

youtu.be

Walk With Me: Carolyn Bertozzi, chemical biologist studying how sugars on cells shape disease

YouTube video by Stanford Medicine

164

Reposted by Ann Mullally

Stanford Medicine @stanfordmedicine.bsky.social · 19/03/2026

Walk with Me: Fatima Rodriguez studies heart disease prevention and population health to improve outcomes by reaching patients earlier. Hear what inspired her path—and how she starts each day. www.youtube.com/watch?v=0U_X... @stanforddeptmed.bsky.social @stanfordcdh.bsky.social

youtube.com

Walk With Me: Fatima Rodriguez, cardiologist studying heart disease prevention

YouTube video by Stanford Medicine

033

Reposted by Ann Mullally

Stanford Medicine @stanfordmedicine.bsky.social · 12/03/2026

Meet Steven Artandi, a physician-scientist who studies cancer biology. His work helps uncover the mechanisms that enable cancer to grow and persist. Learn what he wanted to be when he was a kid — and the quote he lives by. youtu.be/UWwT5owtCdc?... @stanford-cancer.bsky.social

youtu.be

Walk With Me: Steven Artandi, oncologist studying cancer biology and aging

YouTube video by Stanford Medicine

1104

Reposted by Ann Mullally

ISEH - International Society for Experimental Hematology @isehsociety.bsky.social · 25/03/2026

Submit your abstract by 17 April for opportunities to present your work at #ISEH2026! Don't miss this opportunity to present your work to hematology researchers from around the world. Please note that no extensions will be offered. Learn more: iseh.org/Annual-Meeti...

002

Reposted by Ann Mullally

Stanford Medicine @stanfordmedicine.bsky.social · 24/03/2026

Walk with Me: Meet Paul Mischel, who studies how cancer cells grow, evolve, and resist treatment. His lab has uncovered key drivers of aggressive cancers. Discover what led him to this work — and his favorite comfort meal. youtu.be/SlPd-Pdvs-k?... @stanford-cancer.bsky.social

youtu.be

Walk With Me: Paul Mischel, physician-scientist studying cancer evolution

YouTube video by Stanford Medicine

0114

Reposted by Ann Mullally

American Society of Hematology @ash.hematology.org · 23/03/2026

Contributing Editor Dr. Brierley, sits down with myeloid neoplasms expert Dr. Garcia to unpack the VERONA trial and what its findings mean for patients and clinicians in the myelodysplastic syndromes community. Tune in: ow.ly/xHQn50YxQce #Hematology

011

Reposted by Ann Mullally

mpnrf.bsky.social @mpnrf.bsky.social · 20/03/2026

Congratulations to @mullallylab.bsky.social and colleagues on a new study clarifying risk in TP53-mutated #MPNs. By defining key factors that shape disease course, this work supports more informed monitoring. Learn more here: f.mtr.cool/stzyrutxoc #MPNresearch #bloodcancer

001

Ann Mullally @mullallylab.bsky.social · 19/03/2026

Honored to contribute to @bloodjournals.hematology.org "New Wave of Targeted Therapies in #MPN" review series curated by Dr. Jason Gotlib, thankful to my awesome co-author Dr. Gabriel Salzman! Article link: lnkd.in/gBjUi4R9 @stanforddeptmed.bsky.social @ash.hematology.org @mpnrf.bsky.social #MPNsm

042

Reposted by Ann Mullally

The Lancet @thelancet.com · 14/03/2026

Sickle cell disease is a genetic red blood cell disorder, affecting nearly 8 million of people globally. A new Seminar provides a comprehensive update & overview of the disease ▶️ spkl.io/63328AIshA

Figure: Cyclic pathophysiology of sickle cell disease and main cellular interactions and processes that lead to vaso-occlusion and tissue injury. Copyright: Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

085

Ann Mullally @mullallylab.bsky.social · 11/03/2026

Delighted to welcome Dr. Shruti Chaturvedi to #Stanford Hematology to speak on her important work on thrombotic microangiopathies, complement activation & antiphospholipid syndrome, looking forward to it! @stanforddeptmed.bsky.social

031

Ann Mullally @mullallylab.bsky.social · 11/03/2026

Fantastic to have Dr. Alexis Thompson visit #Stanford Advances in the treatment of #SickleCellDisease have been extraordinary, extending access to more patients is critical - check out #FutureofMedicine podcast with our Chair, Dr. Euan Ashley! @euanashley.bsky.social @stanforddeptmed.bsky.social

010

Reposted by Ann Mullally

Mick Milsom @milsommick.bsky.social · 06/03/2026

Abstract submission for the Mol Hem Workshop is now open here ehaweb.org/connect-netw... Submit for your chance to present your latest unpublished work in a highly visible session that forms part of the EHA annual meeting program in Stockholm.

ehaweb.org

EHA2026 Molecular Hematopoiesis Workshop - The European Hematology Association (EHA)

076

Reposted by Ann Mullally

Ya’el Courtney, PhD @scienceyael.bsky.social · 05/03/2026

When I was choosing between PhD programs, I had a hard time gauging what mattered most. Everyone I asked valued something different, which made it even harder to figure out what I should be weighing. Wrote up the framework I wish I'd had: www.yaelcourtney.com/resources-an...

yaelcourtney.com

How to Choose a PhD Program — Ya'el Courtney

Deciding between PhD program offers? A framework for evaluating funding, culture, advisors, and fit — from a coach who chose between Harvard and Stanford and now helps students make this decision ever...

072

Reposted by Ann Mullally

American Society of Hematology @ash.hematology.org · 02/02/2026

Nominations are open for 2027 ASH committee and leadership positions! Step forward or recommend a colleague to help shape #hematology initiatives, support research, and bring new perspectives to the Society. 🔗 Submit your nomination now: ow.ly/WOYa50Y7Fci #HemeSky #MedSky

022

Reposted by Ann Mullally

Science Magazine @science.org · 08/01/2026

You don’t need a brain to benefit from a good night of sleep. Despite lacking a central nervous system, jellyfish and sea anemones have sleep patterns remarkably similar to those of humans, researchers report. Learn more: scim.ag/3NgeAEQ

16721

Reposted by Ann Mullally

Elizabeth McKenna @elizsmckenna.bsky.social · 07/01/2026

Now online in Cancer Discovery @aacrjournals.bsky.social: Genotype-to-Phenotype Mapping of Somatic Clonal Mosaicism via Single-Cell Co-Capture of DNA Mutations & mRNA Transcripts by @dennisjyuan.bsky.social, @landau.bsky.social, et al. doi.org/10.1158/2159... @nygenome.org @weillcornell.bsky.social

085

Reposted by Ann Mullally

Blood Journals Portfolio @bloodjournals.hematology.org · 07/01/2026

We're excited to share that Blood Advances has a new Associate Editor, Dr. Steven Lane. He's a clinical hematologist and researcher at Royal Brisbane & Women's Hospital and runs a busy research group at the Queensland Institute of Medical Research. Welcome Dr. Lane! #BloodAdvances

021

Reposted by Ann Mullally

mpnrf.bsky.social @mpnrf.bsky.social · 07/01/2026

The MPN Challenge™ funding cycle is now open. Find further details on eligibility, proposal guidelines, and deadlines. goto.mpnresearchfoundation.org/49ix…. Proposals are due by March 23, 2026 at 11:59PM CT. #2026MPNChallenge #MPNChallenge #RFA #MPNFundingOpportunity #MPNRF

001

Reposted by Ann Mullally

Itai Yanai @itaiyanai.bsky.social · 06/01/2026

Papers submitted on Tuesdays are more likely to be accepted by Nature whereas Wednesdays seem the most likely day to submit and secure acceptance to PLOS ONE. For Cell, Mondays and Tuesdays seem the best submission days in case of accepted papers. link.springer.com/article/10.1...

1207

Ann Mullally @mullallylab.bsky.social · 06/01/2026

Fascinating study on Anna’s hummingbird, one of the many beautiful birds I frequently see on the Stanford campus! 🐦 @stanforduniversity.bsky.social

020

Ann Mullally @mullallylab.bsky.social · 05/01/2026

Excited to kick off 2026 with a #Hematology seminar from Arun Wiita, MD, PhD on Jan 8th! Arun has pioneered proteomics to characterize aberrantly expressed cell surface proteins in #bloodcancers, to identify novel targets for #immunotherapy, looking forward to this! @stanforddeptmed.bsky.social

030

Reposted by Ann Mullally

Stanford Department of Medicine @stanforddeptmed.bsky.social · 12/12/2025

Coming next week on The Future of Medicine: Jennifer Doudna, a Nobel Prize–winning biochemist & the co-inventor of CRISPR gene editing! #StanDOM's @euanashley.bsky.social & Doudna discuss scientific curiosity, responsible innovation, gene editing & more. bit.ly/43LGRZv

042

Reposted by Ann Mullally

Stanford Department of Medicine @stanforddeptmed.bsky.social · 11/12/2025

At a recent #MedicineGrandRounds, @childrensphila.bsky.social's Alexis Thompson discussed her groundbreaking research on #SickleCellDisease. Her clinical research was instrumental in the approval of the first gene therapies for sickle cell disease. 📸 by Clinton Louie

051

Reposted by Ann Mullally

Peggy Goodell @goodell-lab.bsky.social · 12/12/2025

Today's the print release of a #RibackLab and #GoodellLab collaboration— we’re excited to share the visual story behind the science, including the dramatic artwork that inspired how we thought about aberrant function of NPM1c - which occurs in about 1 in 3 adult acute myeloid leukemias (#AML).

1188

Reposted by Ann Mullally

ernstlaboratory.bsky.social @ernstlaboratory.bsky.social · 09/12/2025

One of my favorite pics of the Myeloid Workshop at #ASH2025. Not at all challenging to find female speakers; thanks to ASH and the excellent section leaders for making this happen!

071

Reposted by Ann Mullally

American Society of Hematology @ash.hematology.org · 09/12/2025

The gavel has officially passed at #ASH25. Thank you, Dr. Avalos, for your outstanding leadership. And welcome to Dr. Robert Negrin, whose dedication to mentorship, discovery, and advancing hematology will continue to strengthen the field.

0151

Reposted by Ann Mullally

Itai Yanai @itaiyanai.bsky.social · 09/12/2025

There’s an art to writing a grant proposal so that your creativity is on full display. Maria Leptin - president of the ERC - talks about it on the new episode of the Night Science Podcast.

24511

Reposted by Ann Mullally

Dana-Farber Cancer Institute @danafarber.bsky.social · 06/12/2025

Lachelle Weeks, MD, PhD, shares findings that demonstrate sickle cell disease may predispose patients to high-risk clonal hematopoiesis. This multinational cohort defined CH prevalence, age distribution, and mutational profiles in SCD relative to non‐SCD controls and other hemoglobinopathies. #ASH25

041

Reposted by Ann Mullally

Stanford Department of Medicine @stanforddeptmed.bsky.social · 04/12/2025

EBV & Lupus — A Breakthrough Publication of 2025 Announced in Nov. 2025, a landmark Science Translational Medicine study from #StanDOM's William H. Robinson revealed how the common Epstein-Barr virus can infect & reprogram immune cells to trigger lupus. stanford.io/3LUx3Gg

011

Reposted by Ann Mullally

Eric Topol @erictopol.bsky.social · 21/11/2025

“I had hemophilia for nearly five decades. I went to Philadelphia and had a 45-minute infusion, and my hemophilia was gone.” Genes-> Medicine nature.com/articles/s41...

1236785

Ann Mullally @mullallylab.bsky.social · 04/12/2025

Ah, how I miss New England! 🥶 🤣

020

Reposted by Ann Mullally

Stanford Department of Medicine @stanforddeptmed.bsky.social · 25/11/2025

Here's your first look at The Future of Medicine, our new #StanDOM podcast launching Dec. 1! Meet host @euanashley.bsky.social & hear more about the exciting paths we will chart together! Subscribe anywhere you listen to podcasts or watch on YouTube at bit.ly/44vtyMX

021

Reposted by Ann Mullally

American Society of Hematology @ash.hematology.org · 24/11/2025

The highly anticipated #ASH25 late-breaking abstracts have been posted: ow.ly/EGCi50XwYbf 👏 #ASHKudos to the presenters! Discover more important and novel research at the 67th ASH Annual Meeting. It's not too late to register! #Hemesky #Medsky

052

Reposted by Ann Mullally

Vijay G. Sankaran @bloodgenes.bsky.social · 24/11/2025

If you have not read this moving and courageous essay from Tatiana Schlossberg in the @newyorker.com, please check it out. You may be wondering why inv(3) leukemia is so deadly? Here is a brief 🧵 (1/n)

184